GlassScriptPhysician profile
Michael Hunter
NPI 1528447521
$16,376.36
in general payments reported to CMS, 2019-2025
36 companies · $1,804 in 2025
The $1,804 reported for 2025 was more than what 80% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,343 · 2020: $2,377 · 2021: $2,160 · 2022: $2,403 · 2023: $2,202 · 2024: $2,088 · 2025: $1,804.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,594 · Consulting Fee: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,593.69 |
| Consulting Fee | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $7,914.23 | 2019-2025 | Proclaim, Eterna, Ionicrf |
| Boston Scientific Corporation | $2,209.71 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Si-Bone, INC. | $1,690.91 | 2019-2025 | |
| Zavation Medical Products, LLC | $500.00 | 2023 | |
| Nalu Medical, INC. | $451.09 | 2021-2025 | Nalu Neurostimulation System |
| Medtronic, INC. | $402.37 | 2021-2025 | Catalyft Pl Expandable Interbody System, Intellis Adaptivestim |
| Stimwave Technologies Incorporated | $343.67 | 2019-2022 | |
| Nevro Corp. | $332.44 | 2022-2023 | Senza |
| Genesys Orthopedics Systems, L.L.C. | $322.25 | 2022 | |
| Collegium Pharmaceutical, INC. | $281.94 | 2020-2023 | Belbuca, Xtampza |
| Globus Medical, INC. | $256.13 | 2025 | Vyrsa V1, Senza |
| Scilex Pharmaceuticals INC. | $182.51 | 2020-2023 | Ztlido |
| Abbvie INC. | $179.90 | 2021-2025 | |
| Averitas Pharma INC. | $165.31 | 2023-2025 | Qutenza |
| Painteq LLC | $141.43 | 2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $137.17 | 2020 | |
| Curonix LLC | $136.61 | 2022-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Biodelivery Sciences International, INC. | $95.96 | 2019-2021 | |
| Vertos Medical, INC. | $83.83 | 2024 | Mild Device Kit |
| Biotronik Nro, INC. | $57.51 | 2024-2025 | Prospera |
| Tersera Therapeutics LLC | $55.48 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $51.86 | 2020-2024 | Ajovy |
| Pfizer INC. | $47.69 | 2019-2023 | |
| Vertex Pharmaceuticals Incorporated | $47.38 | 2024-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $38.07 | 2022-2025 | Relistor |
| Valinor Pharma, LLC | $36.95 | 2025 | Movantik |
| Grt US Holding, INC. | $32.15 | 2022 | |
| Ibsa Pharma INC. | $28.73 | 2023 | Tirosint, Licart |
| Stryker Corporation | $28.49 | 2025 | Mild Device Kit |
| Electromed, INC. | $27.48 | 2023 | Smartvest |
| Depuy Synthes Sales INC. | $20.50 | 2024 | Orthovisc, Monovisc |
| Fidia Pharma USA INC. | $19.30 | 2023 | Triluron, Hymovis |
| Spr Therapeutics, INC | $17.63 | 2022 | |
| Bioventus LLC | $17.56 | 2020 | |
| Saluda Medical Americas, INC. | $12.74 | 2024 | Evoke |
| Mml US, INC. | $9.38 | 2025 | Reactiv8 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Hunter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.